Evaluation of serum moesin and podocalyxin levels in patients with diabetes mellitus


Genc S., AKSU O., Can U., ÇALIŞKAN BURGUCU H., ÇELİKDELEN S. Ö., Stevuljevic J. K., ...Daha Fazla

Open Medicine (Poland), cilt.21, sa.1, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 1
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1515/med-2026-1421
  • Dergi Adı: Open Medicine (Poland)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, Directory of Open Access Journals, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
  • Anahtar Kelimeler: diabetic nephropathy, moesin, podocalyxin, biomarkers, endothelial dysfunction, podocyte injury
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objectives: Diabetic nephropathy (DN) is a major microvascular complication of diabetes and a leading cause of end-stage renal disease. Reliable biomarkers for early DN detection remain limited. Moesin and podocalyxin, involved in endothelial and podocyte integrity, may contribute to DN pathophysiology. This study evaluated whether serum moesin and podocalyxin levels differ according to the presence of early-stage DN in type 2 diabetes. Methods: In this single-center cross-sectional study, 63 patients with type 2 diabetes and 27 healthy controls were included. Diabetic participants were classified as normoalbuminuric diabetes (DM) or microalbuminuric early DN (DNP) based on spot urine albumin-to-creatinine ratio. Serum moesin and podocalyxin levels were measured by ELISA. Group comparisons and regression analyses were performed. Results: Both biomarkers were significantly lower in diabetic patients than in controls (p<0.001), but no difference was observed between DM and DNP after age adjustment. Neither biomarker independently predicted nephropathy. A composite factor including moesin, podocalyxin, age, white blood cell count, and microalbuminuria was associated with DN (OR 4.03, 95% CI 1.42-11.47, p=0.009). Conclusions: Serum moesin and podocalyxin decrease in type 2 diabetes but do not independently distinguish early DN, suggesting limited kidney-specific utility.